releving letter

-


This is to inform you that your resignation has been accepted and you are relieved from the services of laborate pharma on the close of working hours on 5 july 2018. You are requested to deposit the company Id .We wish you all success in your future endeavors. Best Wishes,
ALL THE BEST.




                                      TO WHOMSOVER IT MAY CONCERN


  This is to certify that Mr. BHUPESH SOLANKI  was working at LABORATE PHARMACEUTICAL INDIA LTDAs PRODUCTION CHMIST  from 1 JUNE 2017 to 5 JULY 2018. During his tenure, we found him to be good knowledge and good practice his services were found to be satisfactory. We wish him all the best in his future endeavors

Comments

Post a Comment

Popular posts from this blog

-
1. TABLETS General chapter 2. TABLETS • Tablets are solid dosage form each containing a unit dost of one or more medicament • Intended for oral administration • Some tablets are swallowed whole or after being chewed • some are dissolved or dispersed in water before administration • some are retained in the mouth where the active ingredient is liberated. 3. TABLETS • Because of their composition, method of manufacture or intended use, tablets present a variety of characteristics and consequently there are several categories of tablets. • Unless otherwise stated in the individual monograph, tablets are uncoated. 4. Different types of tablets • Uncoated tablets • Film Coated • Sugar Coated • Dispersible Tablets • Effervescent Tablets • Modified-release Tablets • Enteric-coated Tablets • Prolonged- release Tablets • Soluble Tablets • Tablets for Use in the Mouth
Read more

I.P LIMIT

-
Image
Tablet weight is mainly affected by factors such as tooling of the compression machine,head pressure,machine speed and flow properties of the powder.Inconsistent powder or granulate density and particle size distribution are common sources of weight variation during compression. Variation between tablet with respect to dose and weight must be reduced to a minimum.Uniformity of weight is an in process test parameter which ensures consistency of dosage units during compression. Test Procedure Weigh individually 20 units selected at random and calculate the average weight.Not more than two of the individual weights deviates from the average weight by more than the percentage given in the pharmacopea and none deviates by more than twice that percentage.IP/BP & USP limits for tablet weight variation is given below.                                          IP/BP   Limit USP 80 mg or less ± 10% 130mg
Read more